1 Min Read
* Says it gets patent in Malaysia, for its new anti-hepatocellular carcinoma drug OB318
Source text in Chinese: goo.gl/sqVuKi
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.